RLS drug study probes genetic changes behind worsening symptoms
NCT ID NCT06726785
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 37 times
Summary
This study looks at how taking certain RLS medications for a long time may change the activity of genes related to dopamine. Researchers will collect nasal swabs from 50 adults with RLS who have either just started or been on these drugs for 6+ months. The goal is to understand why some people develop worsening symptoms, called augmentation, after prolonged use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEG SYNDROME (RLS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alethios Inc
RECRUITINGSan Francisco, California, 94109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.